Production (Stage)
Foghorn Therapeutics Inc.
FHTX
$4.32
-$0.22-4.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 220.59M | 243.75M | 267.40M | 285.18M | 206.66M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.83M | 5.85M | 3.84M | 4.44M | 4.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 225.42M | 249.60M | 271.23M | 289.62M | 211.52M |
|
|
|||||
| Total Current Assets | 225.42M | 249.60M | 271.23M | 289.62M | 211.52M |
| Net Property, Plant & Equipment | 31.54M | 32.61M | 34.58M | 36.26M | 40.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.73M | 1.78M | 2.56M | 2.71M | 2.76M |
| Total Assets | 258.69M | 283.98M | 308.37M | 328.59M | 255.00M |
|
|
|||||
| Total Accounts Payable | 4.07M | 3.79M | 3.45M | 4.81M | 5.63M |
| Total Accrued Expenses | 6.45M | 8.53M | 11.22M | 6.45M | 5.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.11M | 9.07M | 8.77M | 8.38M | 8.67M |
| Total Finance Division Other Current Liabilities | 51.67M | 45.61M | 33.38M | 31.23M | 32.18M |
| Total Other Current Liabilities | 51.67M | 45.61M | 33.38M | 31.23M | 32.18M |
| Total Current Liabilities | 71.31M | 66.99M | 56.82M | 50.87M | 52.07M |
|
|
|||||
| Total Current Liabilities | 71.31M | 66.99M | 56.82M | 50.87M | 52.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.74M | 28.06M | 30.30M | 32.54M | 34.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 223.30M | 234.46M | 249.54M | 259.50M | 266.11M |
| Total Liabilities | 320.34M | 329.51M | 336.66M | 342.91M | 352.49M |
|
|
|||||
| Common Stock & APIC | 515.35M | 512.52M | 510.03M | 505.58M | 399.59M |
| Retained Earnings | -577.02M | -558.18M | -538.68M | -519.56M | -496.58M |
| Treasury Stock & Other | 14.00K | 135.00K | 360.00K | -338.00K | -497.00K |
| Total Common Equity | -61.65M | -45.53M | -28.29M | -14.32M | -97.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -61.65M | -45.53M | -28.29M | -14.32M | -97.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -61.65M | -45.53M | -28.29M | -14.32M | -97.49M |
|
|
|||||